All Stories

  1. A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer
  2. Severe Bleeding after Percutaneous Transhepatic Drainage of the Biliary System: Effect of Antithrombotic Agents—Analysis of 34 606 Cases from a Japanese Nationwide Administrative Database
  3. EUS-guided, through-the-needle forceps biopsy: a novel tissue acquisition technique
  4. TOKYO criteria 2014 for transpapillary biliary stenting
  5. Smoking, Family History of Cancer, and Diabetes Mellitus Are Associated With the Age of Onset of Pancreatic Cancer in Japanese Patients
  6. Clinical outcomes of secondary gastroduodenal self‐expandable metallic stent placement by stent‐in‐stent technique for malignant gastric outlet obstruction
  7. Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer
  8. A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer
  9. Endoscopic Minor Papilla Balloon Dilation for the Treatment of Symptomatic Pancreas Divisum
  10. A R0 Resection Case of Initially Unresectable Metastatic Pancreatic Cancer Downstaged by FOLFIRINOX Therapy
  11. Can we develop self-expandable metallic stents without consideration of mechanical properties?
  12. Metallic stent with high axial force as a risk factor for cholecystitis in distal malignant biliary obstruction
  13. Improved survival with combined gemcitabine and S‐1 for locally advanced pancreatic cancer: pooled analysis of three randomized studies
  14. Endoscopic removal of a proximally migrated pancreatic stent using a gooseneck snare
  15. Transmural Biliary Drainage Can Be an Alternative to Transpapillary Drainage in Patients with an Indwelling Duodenal Stent
  16. 833 A Pilot Study of EUS-Guided Through-the-Needle Biopsy (EUS-TTNB) of Solid Masses
  17. Su1627 A Pilot Study of New Covered Metallic Stents With a Large Bore Size (Niti-S SUPREMO-12 stent) for Unresectable Distal Biliary Malignancies: Newcomer-12 Study
  18. Su1682 Risk Factors for Post-ERCP Pancreatitis in Therapeutic Biliary ERCP Using Wire-guided Cannulation
  19. 830 International Multicenter Comparative Trial of EUS-Guided Biliary Drainage Done by Hepatogastrostomy vs. Choledochoduodenostomy Approaches in 150 Patients
  20. Probe-based confocal laser endomicroscopy of the duodenal mucosa with fluorescein dispersion
  21. Intravenous and Intraperitoneal Paclitaxel with S-1 for Refractory Pancreatic Cancer with Malignant Ascites: an Interim Analysis
  22. Severe Bleeding and Perforation Are Rare Complications of Endoscopic Ultrasound-Guided Fine Needle Aspiration for Pancreatic Masses: An Analysis of 3,090 Patients from 212 Hospitals
  23. Disease-Specific Mortality Among Patients With Intraductal Papillary Mucinous Neoplasm of the Pancreas
  24. Slow Pull Versus Suction in Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Pancreatic Solid Masses
  25. Detection of painless pancreatitis by computed tomography in patients with post-endoscopic retrograde cholangiopancreatography hyperamylasemia
  26. Incidence of Malignancies in Patients with IgG4-related Disease
  27. A novel basket catheter to facilitate endoscopic removal of pancreatic stones (with video)
  28. Trimming a covered metal stent during hepaticogastrostomy by using argon plasma coagulation
  29. Results of the Tokyo Trial of Prevention of Post-ERCP Pancreatitis with Risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial
  30. A Novel, Fully Covered Laser-Cut Nitinol Stent with Antimigration Properties for Nonresectable Distal Malignant Biliary Obstruction: A Multicenter Feasibility Study
  31. Role of endoscopic ultrasonography in pancreatic cystic neoplasms: Where do we stand and where will we go?
  32. Tips and troubleshooting for transpapillary metal stenting for distal malignant biliary obstruction
  33. A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer
  34. Impact of hospital volume on outcomes in acute pancreatitis: a study using a nationwide administrative database
  35. Continuous regional arterial infusion for acute pancreatitis: a propensity score analysis using a nationwide administrative database
  36. A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2
  37. Multicenter retrospective study of endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction in Japan
  38. A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer
  39. Confocal laser endomicroscopy in gastrointestinal and pancreatobiliary diseases
  40. Two Meta-analyses With Different Conclusions: Stent Outcomes Should Be Standardized Before Their Integration
  41. High single-pass diagnostic yield of a new 25-gauge core biopsy needle for EUS-guided FNA biopsy in solid pancreatic lesions
  42. Rarity of Severe Bleeding and Perforation in Endoscopic Ultrasound-Guided Fine Needle Aspiration for Submucosal Tumors
  43. Estimation and comparison of cumulative incidences of biliary self‐expandable metallic stent dysfunction accounting for competing risks
  44. Su1420 Endoscopic Management of Biliary Strictures After Adult Living Donor Liver Transplantation With Duct-to-Duct Reconstruction
  45. Mo1532 A Multicenter Retrospective Study of Endoscopic Ultrasound-Guided Biliary Drainage (EUS-BD) for Malignant Biliary Obstruction in Japan
  46. Tu1304 Endoscopic Closure for Prevention of Bleeding After Endoscopic Ampullectomy
  47. Risk for Mortality From Causes Other Than Pancreatic Cancer in Patients With Intraductal Papillary Mucinous Neoplasm of the Pancreas
  48. Preliminary report on a new, fully covered, metal stent designed for the treatment of pancreatic fluid collections
  49. Mo1552 Feasibility and Efficacy of a 12-CM Long Covered Metallic Stent for EUS-Guided Hepaticogastrostomy (EUS-HGS) for Unresectable Malignant Biliary Obstruction
  50. 775 Evaluation of the Kansas City Criteria for Diagnosing Gastric Dysplasia Using Probe Based Confocal LASER Endomicroscopy (pCLE) “Dorothy, Are We Still in Kansas?”
  51. Mo1513 A Retrospective Analysis of Serial Fluid Analysis of Pancreatic Cystic Neoplasms Under EUS Surveillance: Is There Any Role in Repeat Cyst Fluid CEA Measurement?
  52. Mo1498 A Comparative Study of Suction Technique vs. Slow Pull Technique in EUS-FNA for Pancreatic Malignant Lesions
  53. Su1390 A Prospective Feasibility Study of Preoperative Biliary Drainage Using Fully-Covered Self-Expandable Metallic Stent for Pancreatic Head Cancer
  54. Mo1502 Endoscopic Ultrasound (EUS) Guided Biopsy of the Pancreas Surface Using a Novel “Through-the-Needle” Technique: Can We Biopsy the Pancreas Without Trauma to the Ducts?
  55. Sa1394 New Submucosal Lifting Gel for Endoscopic Submucosal Dissection of Gastrointestinal Lesions: ESD Made Easy With “Needle-Free Auto-Dissection”
  56. Su1388 A Pilot Study of Antireflux Covered Metal Stent for Recurrent Occlusion of Biliary Metal Stents
  57. Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancer
  58. Su1393 A Prospective Multicenter Study of a Fully-Covered Metal Stent in Patients With Distal Malignant Biliary Obstruction: WATCH-2 Study
  59. Su1389 A Multicenter Retrospective Analysis of Risk Factors of Covered Metallic Stent Migration in Patients With Distal Biliary Obstruction by Pancreatic Cancer: Are All Covered Metallic Stents the Same?
  60. Mo1464 The Results of the Tokyo Trial of Prevention of Post-ERCP Pancreatitis With Risperidone-2 (Tokyo P3R-2): a Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial
  61. Novel antireflux covered metal stent for recurrent occlusion of biliary metal stents: A pilot study
  62. Biliary self‐expandable metallic stent for unresectable malignant distal biliary obstruction: Which is better: covered or uncovered?
  63. Endoscopic papillary balloon dilation versus endoscopic sphincterotomy for bile duct stones: Is it time to put a knife down?
  64. Transpapillary versus transmural biliary drainage in patients with an indwelling duodenal stent: when is one indicated over the other?
  65. High single‐session success rate of endoscopic bilateral stent‐in‐stent placement with modified large cell Niti‐S stents for malignant hilar biliary obstruction
  66. Clinical utility of an endoscopic ultrasound-guided rendezvous technique via various approach routes
  67. Endoscopic ultrasonography‐guided pancreatic duct access: Techniques and literature review of pancreatography, transmural drainage and rendezvous techniques
  68. Clinical Outcomes of Chemotherapy for Diabetic and Nondiabetic Patients With Pancreatic Cancer
  69. Japanese severity score for acute pancreatitis well predicts in-hospital mortality: a nationwide survey of 17,901 cases
  70. A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
  71. Tandem stent placement as a rescue for stent misplacement in endoscopic ultrasonography‐guided hepaticogastrostomy
  72. Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstruction
  73. Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction
  74. Current status of chemotherapy for the treatment of advanced biliary tract cancer
  75. A Retrospective Study of Gemcitabine and Cisplatin Combination Therapy as Second-Line Treatment for Advanced Biliary Tract Cancer
  76. Short- and long-term outcomes of endoscopic papillary large balloon dilation with or without sphincterotomy for removal of large bile duct stones
  77. 進行膵癌に対するレニン・アンギオテンシン系抑制による治療成績向上の試み
  78. Competing risk: a potential risk factor for misleading results of length of stent patency
  79. The endoscopic ultrasonography‐guided rendezvous technique for biliary cannulation: a technical review
  80. Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis
  81. Incidental Pancreatic Cysts Found by Magnetic Resonance Imaging and Their Relationship With Pancreatic Cancer
  82. The results of the Tokyo Trial of Prevention of Post-ERCP Pancreatitis with Risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial
  83. Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariate
  84. Response
  85. Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer
  86. Clinical utility of single‐operator cholangiopancreatoscopy using a SpyGlass probe through an endoscopic retrograde cholangiopancreatography catheter
  87. Simultaneous Duodenal Metal Stent Placement and EUS-Guided Choledochoduodenostomy for Unresectable Pancreatic Cancer
  88. Feasibility of a new self‐expandable metallic stent for patients with malignant colorectal obstruction
  89. Successful management of perforation during cystogastrostomy with an esophageal fully covered metallic stent placement
  90. Endoscopic Retrograde Cholangiopancreatography for Distal Malignant Biliary Stricture
  91. Wire-guided cannulation is not an ideal technique for preventing post-ERCP pancreatitis
  92. Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction: the WATCH study
  93. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age
  94. Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1
  95. Sensitivity analysis, not a calculation of sensitivity, is essential in a propensity score analysis
  96. Better stent function with chemotherapy: effects of chemotherapy or just a better prognosis?
  97. Japanese multicenter estimation of wallflex duodenal stent for unresectable malignant gastric outlet obstruction
  98. One- and two-step self-expandable metal stent placement for distal malignant biliary obstruction: a propensity analysis
  99. ENDOSCOPIC REMOVAL OF A SPONTANEOUSLY FRACTURED BILIARY UNCOVERED SELF‐EXPANDABLE METAL STENT
  100. Endoscopic Ultrasound-Guided Antitumor Agents
  101. Endoscopic Ultrasonography-Guided Fine-Needle Aspiration of Pancreatic Cystic Lesions: A Practical Approach to Diagnosis and Management
  102. Sa1504 Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy (EUS-FNAB) Using a Novel 25-Gauge Core Biopsy Needle: Optimizing the Yield of Both Cytology and Histology
  103. 500 Diagnosis of Pancreatic Cysts:Endoscopic Ultrasound, Through-the-Needle Confocal Laser-Induced Endomicroscopy and Cystoscopy Trial (Detect Study)
  104. Sa1530 High Single-Pass Diagnostic Yield (Cytology and Histology) of a Novel 25-Gauge Core Biopsy Needle for Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in Pancreatic Solid Lesions
  105. Tu1693 A Prospective Study of a Wallflex Duodenal Stent for Malignant Gastric Outlet Obstruction
  106. Sa1549 Low Volume Pancreatic Cyst Fluid Acquired by Endoscopic Ultrasound (EUS) Guided FNA: Is It Okay to Dilute It for CEA Measurement?
  107. Sa1537 Prospective Randomized Trial Comparing 19-G Tru-Cut Needle (TCB) and New 19-G Core Histology Needle (CHN) for Endoscopic Ultrasound (EUS) Guided Liver Biopsy in a Porcine Model
  108. Mo1391 Endoscopic Stenting With a New High-Flexible Self-Expandable Metallic Stent for the Management of Malignant Ileocecal Obstruction
  109. Mo1298 Self-Expandable Metallic Stent With High Axial Force is the Risk Factor of Cholecystitis
  110. Management of malignant gastric outlet obstruction with a modified triple-layer covered metal stent
  111. Sa1511 Results of Prospective Randomized Trial on Endoscopic Ultrasound (EUS) Guided Core Biopsy of the Pancreas Comparing Trucut Biopsy Needle (TCB) Versus New Core Histology Needle (Chn, 19G, 22G, and 25g) in a Porcine Model: Which Needle Is Best?
  112. Recent progress in endoscopic ultrasonography guided biliary intervention
  113. Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis
  114. A multicenter, prospective, randomized study of selective bile duct cannulation performed by multiple endoscopists: the BIDMEN study
  115. Newly‐developed, forward‐viewing echoendoscope: A comparative pilot study to the standard echoendoscope in the imaging of abdominal organs and feasibility of endoscopic ultrasound‐guided interventions
  116. Predictive factors of solid food intake in patients with malignant gastric outlet obstruction receiving self‐expandable metallic stents for palliation
  117. Acoustic radiation force impulse elastography for noninvasive assessment of chronic pancreatitis
  118. Risk factors for pancreatitis following transpapillary self-expandable metal stent placement
  119. Impact of introduction of wire‐guided cannulation in therapeutic biliary endoscopic retrograde cholangiopancreatography
  120. Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer
  121. Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage
  122. A large volume of visceral adipose tissue leads to severe acute pancreatitis
  123. Covered metallic stenting for malignant distal biliary obstruction: clinical results according to stent type
  124. Covered biliary metal stent: which are worse—the concepts, current models, or insertion methods?
  125. Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
  126. Specific increase in serum autotaxin activity in patients with pancreatic cancer
  127. Efficacy and safety of covered self-expandable metal stents for management of distal malignant biliary obstruction due to lymph node metastases
  128. Sa1495 The Final Report of WATCH Study; Comparison of Covered WA llflex Sten T With C overed Wallstent As H istorical Control by Japanese Multicenter Study in Cases With Malignant Distal Biliary Obstruction. (UMIN000002293)
  129. 878 Prospective Randomized Comparative Study Using Hemoclip, Endoloop, and Fibrin Sealant for Endoscopic Closure of Iatrogenic Duodenal Perforation in a Porcine Model: HELLP Study
  130. Mo1471 Risk Factors for Pancreatitis Following Transpapillary Self-Expandable Metal Stent Placement
  131. Mo1421 The New Forward Viewing Curvilinear Array Echoendoscope (FVES): Are There Any Disadvantages? A Prospective Comparison Study
  132. Su1442 Dose Extracorporeal Shockwave Lithotripsy Combined With Endotherapy Really Improve the Natural Course of Chronic Pancreatitis?
  133. Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer
  134. A Case of Autoimmune Pancreatitis Diagnosed at the Time of Relapse which Happened Twelve Years after the Initial Onset.
  135. NEW METHOD OF COVERED WALLSTENTS FOR DISTAL MALIGNANT BILIARY OBSTRUCTION TO REDUCE EARLY STENT‐RELATED COMPLICATIONS BASED ON CHARACTERISTICS
  136. Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
  137. Impact of S-1 on the Survival of Patients With Advanced Pancreatic Cancer
  138. Increased liver elasticity in patients with biliary obstruction
  139. Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer
  140. Newly designed large cell Niti-S stent for malignant hilar biliary obstruction: a pilot study
  141. Efficacy of Pancreatic Stenting After Clearance of Pancreatic Stones
  142. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy
  143. A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer
  144. Endoscopic papillary balloon dilation for bile duct stone removal in patients 60 years old or younger
  145. T1371 Intraductal Papillary Mucinous Neoplasms and Extrapancreatic Malignancies: Is it a Real Association or Just a Coincidence?
  146. S1251 Short-Term Antibiotic Therapy for Acute Cholangitis After Successful Endoscopic Biliary Drainage
  147. Bezafibrate for the treatment of primary sclerosing cholangitis
  148. Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis
  149. Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
  150. Measurement of radial and axial forces of biliary self-expandable metallic stents
  151. Covered metallic stents in the management of malignant and benign pancreatobiliary strictures
  152. Management of distal malignant biliary obstruction with the ComVi stent, a new covered metallic stent
  153. Diagnostic utility of biopsy specimens for autoimmune pancreatitis
  154. S1296 Identifying IPMN and Pancreatic Cyst That Develop Conventional Pancreatic Cancer
  155. M1290 Calcification Is a Factor of Cancer Incidence in Chronic Pancreatitis
  156. S1283 Clinical Significance of IgG and IgG4 During Follow-Up of Autoimmune Pancreatitis
  157. M1287 New-Onset Diabetes Mellitus Is Not Associated with the Prognosis of Pancreatic Cancer
  158. NOTES and endoscopic pancreatic necrosectomy for the GI endoscopist
  159. Management of late biliary complications in patients with gallbladder stones in situ after endoscopic papillary balloon dilation
  160. Endoscopic Papillary Balloon Dilation for Bile Duct Stones in Patients Aged 60 Years Old or Younger
  161. Differential Diagnosis Between Adenoma and Carcinoma for the Gastric Superficial Elevated Lesions By Using Magnified Endoscopy Combined with Narrow-Band Imaging
  162. Wire-Guided Cannulation for Therapeutic Biliary ERCP: The Learning Curve and a Matched Case Control Study with Conventional Contrast-Assisted Cannulation
  163. Is the Expansion Rate of the Covered Metallic Stents the Predictive Factor of Patency?
  164. The Results of the Tokyo Trial of Prevention of Post-ERCP Pancreatitis with Risperidone (Tokyo P3R)
  165. S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer
  166. A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer
  167. 膵炎再発予防に対する膵管ステント留置術の有用性
  168. Transluminal endoscopic necrosectomy for infected pancreatic necrosis
  169. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine
  170. Efficacy and Safety of Metallic Stents in Patients With Unresectable Pancreatic Cancer Receiving Gemcitabine
  171. Clinical features of primary sclerosing cholangitis with onset age above 50 years
  172. Intraductal US in the assessment of tumor involvement to the orifice of the cystic duct by malignant biliary obstruction
  173. Management of Occluded Uncovered Metallic Stents in Patients With Malignant Distal Biliary Obstructions Using Covered Metallic Stents
  174. S1785 Liver Elasticity in Patients with Pancreatobiliary Disease
  175. 405 Characteristics of Intraductal Papillary Mucinous Neoplasm and Cyst of the Pancreas That Develop An Infiltrating Ductal Adenocarcinoma During Follow-Up
  176. W1398 Description of Incidental Pancreatic Cysts On Magnetic Resonance Imaging and Relationship to Pancreatic Cancer
  177. S1306 Diagnostic Utility of Biopsy Specimens for Autoimmune Pancreatitis
  178. W1399 Pancreatic Cyst, Not New-Onset Diabetes, Is the Clue to Early Diagnosis of Pancreatic Cancer
  179. Long-Term Outcomes (Mean Follow-Up Period > 10 Years) of Endoscopic Papillary Balloon Dilation for Bile Duct Stones
  180. Risk Factors for Recurrence of Common Bile Duct Stone in Patients with the Gallbladder in Situ with Stones After Endoscopic Papillary Balloon Dilation
  181. Endoscopic Re-Intervention for the Management of Dysfunction of Covered Metallic Stents in Patients with Malignant Distal Biliary Obstructions
  182. Efficacy of Gemcitabine for Locally Advanced Pancreatic Cancer: Comparison with 5-Fluorouracil-Based Chemoradiotherapy
  183. CA 19-9 Response as an Early Indicator of the Effectiveness of Gemcitabine in Patients with Advanced Pancreatic Cancer
  184. Efficacy and safety of low‐pressured and short‐time dilation in endoscopic papillary balloon dilation for bile duct stone removal
  185. Risk factors for acute suppurative cholangitis caused by bile duct stones
  186. Endoscopic Management of Biliary Cast After Living Donor Liver Transplantation
  187. Self-Expandable Metallic Stents for Malignant Biliary Obstruction with Anomalous Pancreaticobiliary Junction
  188. A Result with Newly-Developed Covered Metallic Stent, ComVi Stent
  189. Efficacy and Safety of Metallic Stents in Patients with Unresectable Pancreatic Cancer Receiving Gemcitabine
  190. Endoscopic Transpapillaly Approach for Diagnosis of Gallbladder Cancer
  191. Pancreatic Tuberculosis with a Pancreaticobiliary Fistula
  192. Outcomes after clearance of pancreatic stones with or without pancreatic stenting
  193. Endoscopic Papillary Balloon Dilation for Bile Duct Stone: Immediate and Long-Term Outcomes in 1000 Patients
  194. Endoscopic Management of Biliary Complications after Adult Living Donor Liver Transplantation
  195. Cholecystitis After Metallic Stent Placement in Patients With Malignant Distal Biliary Obstruction
  196. Efficacy of peppermint oil as an antispasmodic during endoscopic retrograde cholangiopancreatography
  197. WHICH TYPES OF DRAINAGE TUBE SHOULD WE SELECT FOR ENDOSCOPIC BILIARY DRAINAGE? CURRENT STATUS
  198. Serum IgG4 concentrations in pancreatic and biliary diseases
  199. The Investigation of Radial and Axial Force in Biliary Metallic Stent
  200. Endoscopic Management of Biliary Complications After Living Donor Liver Transplantation
  201. Outcome in 1,000 Patients with Bile Duct Stones Treated with Endoscopic Papillary Balloon Dilation
  202. Clinical Result with Newly-Developed Covered Metallic Stent, ComVi Stent
  203. Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis
  204. Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction
  205. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial
  206. Inward and Outward Migration of Covered Metallic Stent in Patients with Unresectable Malignant Distal Biliary Obstruction
  207. Non-Surgical Management of Common Bile Duct Stones after Gastrectomy
  208. Covered Wallstent for the Management of Distal Malignant Biliary Obstruction
  209. Successful treatment for groove pancreatitis by endoscopic drainage via the minor papilla
  210. Pancreatic Mass Lesions Associated with Raised Concentration of IgG4
  211. COVERED METALLIC STENTS FOR MANAGEMENT OF DISTAL MALIGNANT BILIARY OBSTRUCTION
  212. Covered Wallstent for the Management of Malignant Biliary Obstruction
  213. Covered Metallic Stents for the Management of Distal Malignant Biliary Obstruction -Risk Factors for the Specific Complications
  214. Utility of Intraductal Ultrasonography for the Assessment of Cystic Duct Patency to Evaluate the Risk of Acute Cholecystitis After Biliary Metallic Stent Placement
  215. Clinico-pathological features of extrapancreatic bile duct abnormalities observed in autoimmune pancreatitis
  216. Indications and Procedure of Biliary Metallic Stenting